Skip to main content

Statin Therapy at Discharge after Lower Extremity Bypass (LEB)

CBE ID
1519
1.4 Project
Surgery
Endorsed
Endorsement Status
Endorsed
1.1 New or Maintenance
Maintenance
E&M Cycle
Full Year 2015
Is Under Review
No
Next Planned Maintenance Review
Surgery Spring 2024
1.3 Measure Description

Percentage of patients aged 18 years and older undergoing infrainguinal lower extremity bypass who are prescribed a statin medication at discharge. This measure is proposed for both hospitals and individual providers.

    • 1.14 Numerator

      Patients undergoing infrainguinal lower extremity bypass who are prescribed a statin medication at discharge.

    • 1.15 Denominator

      All patients aged 18 years and older undergoing lower extremity bypass as defined above who are discharged alive, excluding those patients who are intolerant to statins.

    • Exclusions

      Chart documentation that patient was not an eligible candidate for statin therapy due to known drug intolerance, or patient died before discharge.

    • Most Recent Endorsement Activity
      Endorsed Surgery Project 2015-2017
      Initial Endorsement
      Last Updated